Clincosm LogoSign in Get a demo

B-cell Lymphoma

Showing NaN - NaN of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Malignancy, Non-Hodgkin Lymphoma, B-cell Lymphoma Trial in Worldwide (CTX110)

Recruiting
  • B-cell Malignancy
  • +3 more
  • CTX110
  • Los Angeles, California
  • +27 more
May 6, 2022

B-cell Lymphoma Trial in United States (SD-101, Radiation therapy)

Terminated
Has Results
  • B-cell Lymphoma
  • Stanford, California
  • +4 more
Aug 20, 2020

Relapsed or Refractory Lymphoproliferative Malignancies, Hodgkin's Lymphoma, Peripheral T-cell Lymphoma Trial in United States

Completed
Has Results
  • Relapsed or Refractory Lymphoproliferative Malignancies
  • +4 more
  • Pralatrexate Injection
  • +3 more
  • Los Angeles, California
  • +14 more
Dec 27, 2019

Marginal Zone Lymphoma, B-cell Lymphoma Trial in Worldwide (ibrutinib)

Completed
Has Results
  • Marginal Zone Lymphoma
  • B-cell Lymphoma
  • Tucson, Arizona
  • +24 more
Oct 8, 2019

B-Cell Lymphoma Trial in Worldwide (inotuzumab ozogamicin, Rituximab)

Completed
Has Results
  • B-Cell Lymphoma
  • Birmingham, Alabama
  • +37 more
Feb 6, 2018

Advanced Malignancies, Positive for Anaplastic Lymphoma Kinase, Positive for Proto-Oncogene Tyrosine-Protein Kinase ROS Trial in

Completed
  • Advanced Malignancies
  • +4 more
  • Orange, California
  • +5 more
Jun 27, 2016

B-Cell Lymphoma, B-Cell Leukemia Trial in United States (PCI-32765)

Completed
  • B-Cell Lymphoma
  • B-Cell Leukemia
  • Palo Alto, California
  • +8 more
May 21, 2013

B-Cell Lymphoma, Follicular Lymphoma, Marginal Lymphoma Trial in United States (VELCADE and rituximab)

Completed
  • B-Cell Lymphoma
  • +2 more
  • VELCADE and rituximab
  • Los Angeles, California
  • +12 more
Feb 7, 2008